MRK•benzinga•
Merck & Co Lowers FY2025 Adj EPS Guidance from $8.88-$9.03 to $8.82-$8.97 vs $8.95 Est; Affirms FY2025 Sales Guidance of $64.10B-$65.60B vs $65.00B Est
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 24, 2025 by benzinga